Heart Disease Clinical Trials in Chicago

Showing 241-260 of 511 trials

High Intensity Lipid Lowering Following Acute Coronary Syndromes for Persons Living With HIV

NCT02841774

HILLCLIMBER is a randomized, controlled, open-label phase II trial of moderate dose statin therapy (pravastatin 40mg daily) versus high-dose statin therapy (rosuvastatin 20-40mg daily) in HIV-infected persons taking antiretroviral therapy (ART) who have coronary heart disease (CHD).

HIV InfectionCoronary Heart Disease

Matthew Feinstein10 participantsStarted Nov 2016

Chicago, Illinois, United States

COMPLETED2.2 miles

Advanced Wireless, Wearable Sensors for Continuous Hemodynamic Monitoring

NCT04362553

Percent agreement of vital signs monitoring between the experimental sensor and standard of care monitoring

Congestive Heart Failure

Northwestern University42 participantsStarted Jun 2020

Chicago, Illinois, United States

TERMINATEDNA2.2 miles

SHIELD II Clinical Investigation

NCT02468778

The HeartMate PHP System is a temporary (\<6 hours) ventricular assist device indicated for use during high-risk percutaneous coronary interventions (PCI) performed electively or urgently in hemodynamically stable patients with severe coronary artery disease, when a heart team, including a cardiac surgeon, has determined high-risk PCI is the appropriate therapeutic option. Use of the HeartMate PHP Systems in these patients may prevent hemodynamic instability, which can result from repeat episodes of reversible myocardial ischemia that occur during planned temporary coronary occlusions and may reduce peri-and post-procedural adverse events.

Coronary Artery Disease

Abbott Medical Devices54 participantsStarted Aug 2015

Scottsdale, Arizona, United States • Tucson, Arizona, United States • Los Angeles, California, United States +55 more locations

High Intensity Lipid Lowering Following Acute Coronary Syndromes for Persons Living With HIV

Advanced Wireless, Wearable Sensors for Continuous Hemodynamic Monitoring

SHIELD II Clinical Investigation

Heart Disease Trials in Other Cities

MOMENTUM 3 IDE Clinical Study Protocol

MOMENTUM 3 Continued Access Protocol

Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device (LVAD) and Medical Management

Polydiuretic Therapy for Heart Failure With Preserved Ejection Fraction and Diabetes Mellitus

Coordinating Pragmatic Primary Care Population Management for Obesity

Behavioral and Recovery Support for 30 Day Post-Discharge Care

Physiologic Assessment of Coronary Stenosis Following PCI

Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Bridge to Cardiac Transplantation

Prevention of Non-Surgical Bleeding by Management of HeartMate II Patients Without Antiplatelet Therapy

CentriMag Ventricular Assist System in Treating Failure-to-Wean From Cardiopulmonary Bypass

The Product Surveillance Registry REVERSE Post Approval Study

Imaging of Coronary Plaques in Participants Treated With Evolocumab

A Study to Test the Effect of Empagliflozin in Patients Who Are in Hospital for Acute Heart Failure

Assessment of Safety, Tolerability, Immunogenicity, and Pharmacokinetics of AZD3427

Chronic Total Occlusion Percutaneous Coronary Intervention Study

Physiologic Signals and Signatures With the Accuryn Monitoring System - The Accuryn Registry

The ADAPT Study: Assessment of the DiAgnostic Performance of DeepVessel FFR in SuspecTed Coronary Artery Disease

Other Conditions in Chicago